Return to Home Incidence > Table > Interpret

Interpretation of Incidence Rates Data

Incidence Rate Report for North Carolina by County

Melanoma of the Skin (All Stages^), 2017-2021

All Races (includes Hispanic), Both Sexes, All Ages

Sorted by Rate

Explanation of Column Headers

Objective - The objective of *** is from the Healthy People 2020 project done by the Centers for Disease Control and Prevention.

Incidence Rate (95% Confidence Interval) - The incidence rate is based upon 100,000 people and is an annual rate (or average annual rate) based on the time period indicated. Rates are age-adjusted by 5-year age groups to the 2000 U.S. standard million population.

Recent Trends - This is an interpretation of the AAPC/APC:

AAPC/APC (95% Confidence Interval) - the change in rate over time


Other Notes


Line by Line Interpretation of the Report


North Carolina6


US (SEER+NPCR)1


Watauga County6


Dare County6


Avery County6


Alexander County6


Moore County6


Ashe County6


Madison County6


Brunswick County6


Carteret County6


Iredell County6


Macon County6


Catawba County6


Davie County6


Lincoln County6


Jackson County6


Stanly County6


Chatham County6


Burke County6


Person County6


Polk County6


New Hanover County6


Caldwell County6


Henderson County6


McDowell County6


Rutherford County6


Buncombe County6


Union County6


Transylvania County6


Cleveland County6


Gaston County6


Randolph County6


Yancey County6


Orange County6


Davidson County6


Haywood County6


Mitchell County6


Cherokee County6


Guilford County6


Wilkes County6


Montgomery County6


Surry County6


Columbus County6


Cabarrus County6


Pender County6


Johnston County6


Wake County6


Alamance County6


Stokes County6


Rowan County6


Pasquotank County6


Mecklenburg County6


Onslow County6


Pamlico County6


Camden County6


Yadkin County6


Craven County6


Durham County6


Franklin County6


Granville County6


Lenoir County6


Swain County6


Forsyth County6


Rockingham County6


Vance County6


Caswell County6


Wayne County6


Sampson County6


Currituck County6


Chowan County6


Harnett County6


Wilson County6


Lee County6


Duplin County6


Anson County6


Beaufort County6


Nash County6


Bladen County6


Clay County6


Alleghany County6


Richmond County6


Cumberland County6


Hoke County6


Martin County6


Perquimans County6


Pitt County6


Halifax County6


Edgecombe County6


Scotland County6


Greene County6


Robeson County6


Warren County6


Northampton County6


Bertie County6 Gates County6 Graham County6 Hertford County6 Hyde County6 Jones County6 Tyrrell County6 Washington County6

Notes:
Created by statecancerprofiles.cancer.gov on 12/08/2024 5:50 pm.

State Cancer Registries may provide more current or more local data.
Trend
Rising when 95% confidence interval of average annual percent change is above 0.
Stable when 95% confidence interval of average annual percent change includes 0.
Falling when 95% confidence interval of average annual percent change is below 0.

† Incidence rates (cases per 100,000 population per year) are age-adjusted to the 2000 US standard population (19 age groups: <1, 1-4, 5-9, ... , 80-84, 85+). Rates are for invasive cancer only (except for bladder cancer which is invasive and in situ) or unless otherwise specified. Rates calculated using SEER*Stat. Population counts for denominators are based on Census populations as modified by NCI. The US Population Data File is used for SEER and NPCR incidence rates.
‡ Incidence data come from different sources. The Average Annual Percent Change (AAPC) is based on the APCs calculated by Joinpoint. Due to data availability issues, the time period used in the calculation of the joinpoint regression model may differ for selected counties.

Rates and trends are computed using different standards for malignancy. For more information see malignant.html.

^ All Stages refers to any stage in the Surveillance, Epidemiology, and End Results (SEER) Summary/Historic Combined Summary Stage (2004+).
⋔ Results presented with the CI*Rank statistics help show the usefulness of ranks. For example, ranks for relatively rare diseases or less populated areas may be essentially meaningless because of their large variability, but ranks for more common diseases in densely populated regions can be very useful. More information about methodology can be found on the CI*Rank website.

Φ Rural-Urban Continuum Codes provided by the USDA.
* Data has been suppressed to ensure confidentiality and stability of rate estimates. Counts are suppressed if fewer than 16 records were reported in a specific area-sex-race category. If an average count of 3 is shown, the total number of cases for the time period is 16 or more which exceeds suppression threshold (but is rounded to 3).
1 Source: National Program of Cancer Registries and Surveillance, Epidemiology, and End Results SEER*Stat Database - United States Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute. Based on the 2023 submission.
6 Source: National Program of Cancer Registries SEER*Stat Database - United States Department of Health and Human Services, Centers for Disease Control and Prevention (based on the 2023 submission).
8 Source: Incidence data provided by the SEER Program. AAPCs are calculated by the Joinpoint Regression Program and are based on APCs. Data are age-adjusted to the 2000 US standard population (19 age groups: <1, 1-4, 5-9, ... , 80-84,85+). Rates are for invasive cancer only (except for bladder cancer which is invasive and in situ) or unless otherwise specified. Population counts for denominators are based on Census populations as modified by NCI. The US Population Data File is used with SEER November 2023 data.

Data for the United States does not include data from Indiana.
Data for the United States does not include Puerto Rico.